Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
31/03/2023 02:19
March 31 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT RELATING TO IS
PHASE 2
PARA_008 CLINICAL TRIAL
Source text for Eikon: ID:nASX4SWvlX
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt